memantine has been researched along with Status Epilepticus in 3 studies
Status Epilepticus: A prolonged seizure or seizures repeated frequently enough to prevent recovery between episodes occurring over a period of 20-30 minutes. The most common subtype is generalized tonic-clonic status epilepticus, a potentially fatal condition associated with neuronal injury and respiratory and metabolic dysfunction. Nonconvulsive forms include petit mal status and complex partial status, which may manifest as behavioral disturbances. Simple partial status epilepticus consists of persistent motor, sensory, or autonomic seizures that do not impair cognition (see also EPILEPSIA PARTIALIS CONTINUA). Subclinical status epilepticus generally refers to seizures occurring in an unresponsive or comatose individual in the absence of overt signs of seizure activity. (From N Engl J Med 1998 Apr 2;338(14):970-6; Neurologia 1997 Dec;12 Suppl 6:25-30)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with memantine increase latency to SE onset only in groups treated 3 h before or concomitant with pilocarpine." | 5.48 | Memantine decreases neuronal degeneration in young rats submitted to LiCl-pilocarpine-induced status epilepticus. ( de Oliveira, DL; Dos Santos, TG; Kalinine, E; Mussulini, BHM; Portela, LVC; Zenki, KC; Zimmer, ER, 2018) |
| "Treatment with memantine increase latency to SE onset only in groups treated 3 h before or concomitant with pilocarpine." | 1.48 | Memantine decreases neuronal degeneration in young rats submitted to LiCl-pilocarpine-induced status epilepticus. ( de Oliveira, DL; Dos Santos, TG; Kalinine, E; Mussulini, BHM; Portela, LVC; Zenki, KC; Zimmer, ER, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Spampanato, J | 1 |
| Bealer, SL | 1 |
| Smolik, M | 1 |
| Dudek, FE | 1 |
| Zenki, KC | 1 |
| Kalinine, E | 1 |
| Zimmer, ER | 1 |
| Dos Santos, TG | 1 |
| Mussulini, BHM | 1 |
| Portela, LVC | 1 |
| de Oliveira, DL | 1 |
| Kalemenev, SV | 1 |
| Zubareva, OE | 1 |
| Sizov, VV | 1 |
| Lavrent'eva, VV | 1 |
| Lukomskaya, NY | 1 |
| Kim, KK | 1 |
| Zaitsev, AV | 1 |
| Magazanik, LG | 1 |
3 other studies available for memantine and Status Epilepticus
| Article | Year |
|---|---|
Delayed Adjunctive Treatment of Organophosphate-Induced Status Epilepticus in Rats with Phenobarbital, Memantine, or Dexmedetomidine.
Topics: Animals; Anticonvulsants; Brain; Cell Death; Dexmedetomidine; Disease Models, Animal; Dose-Response | 2020 |
Memantine decreases neuronal degeneration in young rats submitted to LiCl-pilocarpine-induced status epilepticus.
Topics: Animals; Brain; Excitatory Amino Acid Antagonists; Female; Lithium Chloride; Male; Memantine; Neuron | 2018 |
Memantine attenuates cognitive impairments after status epilepticus induced in a lithium-pilocarpine model.
Topics: Animals; Cognition; Cognitive Dysfunction; Exploratory Behavior; Extinction, Psychological; Lithium; | 2016 |